ArticleAmerican journal of cancer research2022

Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.

Po-Yao Hsu et al.PubMed ↗Full text ↗

No numbers read from the abstract.